Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-29 @ 2:22 PM
Study NCT ID:
NCT02320292
Status:
TERMINATED
Last Update Posted:
2025-07-09
First Post:
2014-12-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-15
First Submit QC Date:
None
Study First Post Date:
2014-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-25
Results First Submit QC Date:
None
Results First Post Date:
2023-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-19
Last Update Post Date:
2025-07-09
Last Update Post Date Type:
ACTUAL